Skip to content

Succinimide

GENITO URINARY SYSTEM AND SEX HORMONES

Also known as: butanimide, succinic acid imide, succinic imide

ATC G04BX10

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Succinimide is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including Cereblon isoform 4 and CRBN. Recorded indications include Primary hyperoxaluria.

  • Molecular targets: Cereblon isoform 4 and CRBN (2 listed in DrugCentral).
  • Indications: Primary hyperoxaluria.
  • ATC code: G04BX10 (Other urologicals).
  • Molecular formula: C4H5NO2; molecular weight 99.09 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Primary hyperoxaluria

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Cereblon isoform 4—unknownKi 5.37
Protein cereblonCRBNunknownKi 4.58

ATC classification

ATC codeTherapeutic hierarchy
G04BX10GENITO URINARY SYSTEM AND SEX HORMONES › UROLOGICALS › UROLOGICALS › Other urologicals

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Succinimide is on its molecule page.

Molecular formulaC4H5NO2
Molecular weight99.09 g/mol
CAS number123-56-8
InChIKeyKZNICNPSHKQLFF-UHFFFAOYSA-N
PubChem CID11439
O=C1CCC(=O)N1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Succinimide used for?

DrugCentral lists the following indications for Succinimide: Primary hyperoxaluria.

How does Succinimide work?

Its molecular targets in DrugCentral include Cereblon isoform 4 and CRBN.

What is the chemical formula of Succinimide?

Succinimide has the molecular formula C4H5NO2 and a molecular weight of 99.09 g/mol.

Browse: all drugs starting with S · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets2
Indications1
FormulaC4H5NO2
DrugCentral ID4723
Interactive profile